PaLM Conf Minutes 2016-Sept-14

From IHE Wiki
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Back to IHE Pathology and Laboratory Medicine (PaLM) Domain

Back to IHE Pathology and Laboratory Medicine (PaLM)Technical Committee Page

Recording

The recording for this meeting can be downloaded here: https://drive.google.com/open?id=0BzeZcmIY9FvEWWl5N2tpeWNJV1E

Attendees

Francois Macary, Co-Chair Phast
Raj Dash, Co-Chair CAP
Riki Merrick, Co-Chair APHL
Carolyn Knapik CAP, secretariat
Mary Kennedy CAP, secretariat
Alessandro Sulis CRS4
Daniel Mancusi Systelab
Dan Rutz Epic
David de Mena SAS
Dmytro Rud Roche
Francesca Frexia CRS4
Francesca Vanzo Arsenal IT
Gunter Haroske IHE Germany
James Harrison CAP
JD Nolen Cerner
Laurent Lardin bioMerieux
Megumi Kondo Sakura Finetek Japan

Minutes

Agenda review

  • 1st hour
    • Update on cochair election – Mary:
      • Have received the required number of voters, so voting is now closed.
      • Riki Merrick and Francois have both been re-elected unanimously.
    • Current status of SET – Alessandro:
        • Added the specimen event list.
          • “Specimen aliquoted” - what is the difference to the “Specimen derived” (besides being biobank)?
          • An aliquoted specimen is a type of derived specimen.
          • Aliquoted = body fluid specimen.
          • Derived includes creation of subparts in AP lab.
            • Can someone send a use case for AP lab derived specimen and other pathology domain specific use cases?
        • Categories are unchanged from F2F version.
        • Simplified use case diagrams.
          • Do we want to alter to make clearer that the SEI and SET may sit in different locations?
            • Need one for each organization  (create them as box outlines) of SEI and SET.
            • May also apply to multi-facility set up in the same organization. For same organization, just one SEI and SET, but include a statement that this is an example of software architecture, among others.
          • So far we have the same set up – collection location -> receiving location -> testing location.
            • Should we use the same words for all the use cases and a single diagram where applicable?
            • Different processes for inter-organization over longer distance and intra-organization (requirements of more robust shipping manifest, packaging, etc.) compared to the same building.
        • Biobanking use case described – is it generic enough?
          • Probably should explicitly document  the retrieval for shipment out of biobank (covered in other use cases, so should reference that).
          • Improvement of systems in the future: Full chain of custody and audit change when more than the queried specimen are pulled from the biobank temporarily, since the specimen is in the same holder.
            • This could be handled if the specimen location is part of these transactions, then the systems can do queries on all specimen in the same holder location(s).
            • Fully mapping inventory of specimen (similar to inventory management) on both sides (biobank and consumer) of the testing results (they don’t need the locations, but the related changes that happened because of the locations).
          • Arranging metadata needed for each of the use cases – in Vol 2, specifically for the biobank use case.
    • APSR 2.0
    • Modalities to participate to NLM/CDC meeting on November 8
        • Email update from Ed: The IICC Technical Leadership Team is preparing a draft proposal for a LOINC Format vendors would use to publish the LOINC codes for their IVD Tests. We should be able to share this draft with the PaLM Committee chairs by the end of September.
        • Share registration information, once available.
        • Still waiting for official announcement in the Federal Register.
    • Update on AUTO16 (= IHE-LAW)
        • Email update from Ed: The document has been reviewed by the Document Development Committee, and comments submitted by the committee are being addressed. The document will then be prepared for a 60-day Proposed Draft voting period. CLSI currently estimates publication in June of 2017.
    • Harmonization IHE PaLM/HL7 IGs: agenda for Baltimore (Riki, François)
        • Presenting gap analysis at the HL7 WGM next week.
    • Other Topics
        • None noted
  • No 2nd hour

Next Call: October 12, 2016
    Agenda items for October call:
    • 1st hour: APSR 2.0 review, one more round of SET review, last check on F2F agenda
    • 2nd hour: LSH review (John Hopson)
Retrieved from "http://wiki.ihe.net/index.php?title=PaLM_Conf_Minutes_2016-Sept-14&oldid=98470"